Changeflow GovPing Healthcare & Life Sciences VMD Publishes Packaging Guidance for General Sa...
Routine Guidance Added Final

VMD Publishes Packaging Guidance for General Sales Medicines

Favicon for www.gov.uk UK VMD
Published
Detected
Email

Summary

The VMD has published new guidance clarifying packaging, pack size, and product information requirements for veterinary medicines intended for distribution under the Authorised Veterinary Medicine – General Sales List (AVM-GSL) category. The guidance applies to applicants seeking new marketing authorisations or variations to lower a product's distribution category to AVM-GSL, which permits sale without veterinary, pharmacist, or SQP involvement. Key requirements include clear product information on outer packaging, user-friendly language, and typical maximum pack sizes suitable for general sales distribution.

“AVM-GSL distributed products do not require any discussion between the purchaser and a veterinarian, pharmacist, or suitably qualified person (SQP).”

VMD , verbatim from source
Published by VMD on gov.uk . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors UK VMD for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 8 changes logged to date.

What changed

The VMD has published guidance specifying requirements for veterinary medicines to be authorised at the AVM-GSL distribution category, including what information must appear on outer packaging, required user-friendly language and phrasing, and typical maximum pack sizes. The guidance also clarifies that products under a single marketing authorisation number can have only one distribution category, meaning all pack sizes in that authorisation must comply with AVM-GSL requirements if any are seeking that classification.

Applicants for new products or those seeking to lower an existing product's distribution category (such as from NFA-VPS to AVM-GSL) should review this guidance when preparing their applications. Manufacturers should verify that all pack sizes within any authorisation seeking AVM-GSL status meet the stated packaging and size requirements.

Archived snapshot

Apr 28, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

News story

VMD clarifies packaging requirements for general sales medicines

The VMD has published new guidance on packaging, pack size and product information requirements for products intended to be distributed at AVM-GSL.

From: Veterinary Medicines Directorate Published 27 April 2026

The Veterinary Medicines Directorate (VMD) has published new guidance to help applicants for marketing authorisations or variations to understand the requirements for products to be considered suitable for distribution at Authorised Veterinary Medicine – General Sales List (AVM-GSL).

Why this matters

AVM‑GSL distributed products do not require any discussion between the purchaser and a veterinarian, pharmacist, or suitably qualified person (SQP). It is therefore essential that clear product information is easily available at the point of sale to help purchasers choose the right product for their animal.

Who this guidance is for

This guidance is for anyone intending to submit an application for a product at a distribution category of AVM‑GSL. This includes applications for new products and variations to lower the distribution category, for example moving from NFA‑VPS to AVM‑GSL.

What the guidance covers

The guidance explains:

  • what information should be included on the outer package
  • user‑friendly language, structure and phrases required on the packaging or in the product leaflet if separate
  • the typical maximum pack size considered suitable for AVM-GSL distribution Applicants are reminded that products authorised under one marketing authorisation number can have only a single distribution category and therefore all pack sizes included in this authorisation should comply with the guidance.

About distribution categories

Distribution categories for veterinary medicines determine their supply route based on risk, with requirements for veterinary input decreasing from prescription-only to general sales.

There are four main legal distribution categories for authorised veterinary medicines in the UK:

  • Prescription Only Medicine – Veterinarian (POM-V)
  • Prescription Only Medicine – Veterinarian, Pharmacist, SQP (POM-VPS)
  • Non-Food Animal – Veterinarian, Pharmacist, SQP (NFA-VPS)
  • Authorised Veterinary Medicine – General Sales List (AVM-GSL) Please visit our guidance for more information on how the supply of veterinary medicines are restricted under each of these distribution categories.

Find out more

Read the full guidance: Apply to change a veterinary Marketing Authorisation or Homeopathic Remedy - GOV.UK.

For queries about the guidance, contact: postmaster@vmd.gov.uk.

Share this page

The following links open in a new tab

Updates to this page

Published 27 April 2026

Get daily alerts for UK VMD

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from VMD.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
VMD
Published
April 27th, 2026
Instrument
Guidance
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Drug manufacturers Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Product labeling Marketing authorization Packaging compliance
Geographic scope
United Kingdom GB

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Regulatory Affairs
Topics
Healthcare Consumer Protection

Get alerts for this source

We'll email you when UK VMD publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!